Search For "molnupiravir"
Antiviral drug linked to SARS-CoV-2 mutations: Study
Updated : 5 months, 3 weeks ago IST
Research from the Francis Crick Institute, the University of Cambridge, Imperial College London, the University of Liverpool, the University of Cape Town, and UKHSA has linked molnupiravir, an antiviral drug for COVID-19 infections, and a pattern of mutations in the SARS-CoV-2 virus.
Read More
Researchers find how antiviral drug associated with SARS-CoV-2 mutations
Updated : 2 years, 6 months ago IST
Molnupiravir, an antiviral medication for COVID-19 infections, and a pattern of mutations in the SARS-CoV-2 virus have been linked, according to research from the Francis Crick Institute, the University of Cambridge, Imperial College London, the University of Liverpool, the University of Cap
Read More
Fermenta Biotech Limited exclusively licenses its proprietary enzymatic te
Updated : 4 years, 2 months ago IST
New Delhi [India], January 21 (ANI/PNN): Fermenta Biotech Limited (FBL) today announced that it has signed a Definitive Agreement with Aurigene Pharmaceutical Services Limited (APSL), a stepdown subsidiary of Dr Reddy's Laboratories Limited (DRL).
Read More
COVID treatment guidelines don't include Molnupiravir, Monoclonal antibody
Updated : 4 years, 2 months ago IST
New Delhi [India], January 18 (ANI): According to the revised guidelines issued by AIIMS, ICMR - COVID 19 National Task Force and Joint Monitoring Group (DGHS) under Union Health Ministry for management of adult COVID-19 patients, there is no evidence of injectable steroids in those who does
Read More
Molnupiravir does not come under National Treatment Task Force for COVID-1
Updated : 4 years, 2 months ago IST
New Delhi [India], January 12 (ANI): Antiviral drug Molnupiravir is not included in the National treatment task force for COVID-19, said Director General, Indian Council of Medical Research (ICMR) Balram Bhargava on Wednesday.
Read More
Don't use Molnupiravir for treating COVID-19 in younger population, warns
Updated : 4 years, 2 months ago IST
New Delhi [India], January 11 (ANI): Molnupiravir, an oral antiviral drug used in the treatment of COVID-19 should not be administered to the younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of COVID-19 Working Group of National Technical Advis
Read More
COVID-19: Oral anti-viral drug Molnupiravir is not included in national ta
Updated : 4 years, 2 months ago IST
New Delhi [India], January 5 (ANI): Indian Council of Medical Research (ICMR) head Dr. Balram Bhargava on Wednesday stated that the oral anti-viral drug Molnupiravir capsules are not included in the national task force treatment for COVID-19 as it has side effects.
Read More
Dr Reddy's laboratories gets DCGI's nod to launch Molnupiravir capsules in
Updated : 4 years, 2 months ago IST
Hyderabad (Telangana) [India], December 28 (ANI): Drugs Controller General of India (DCGI) on Tuesday approved Dr Reddy's laboratories for the emergency-use authorisation) to manufacture and market the oral anti-viral drug Molnupiravir capsules 200mg for the treatment of adult patients with
Read More
DCGI grants Cipla emergency use authorisation for COVID-19 drug Molnupirav
Updated : 4 years, 2 months ago IST
Mumbai (Maharashtra) [India], December 28 (ANI): Drug Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation (EUA) to Cipla for the launch of Molnupiravir in the country for COVID-19 treatment.
Read More
Optimus Pharma granted permission for restricted use under emergency situa
Updated : 4 years, 2 months ago IST
Hyderabad (Telangana) [India], December 28 (ANI/PNN): Hyderabad, Optimus Pharma announced launching of their front line COVID-19 medication Molnupiravir in the Indian market, as they have received permission the restricted emergency use for Covid-19 drug.
Read More
Centre clears two new COVID vaccines, one antiviral drug; manufacturers we
Updated : 4 years, 2 months ago IST
New Delhi [India], December 28 (ANI): After the Union Health Ministry cleared two new COVID-19 vaccines and one anti-viral drug for emergency use on Tuesday, vaccine manufacturers welcomed the announcement and said that this would support the patients across India.
Read More
Centre approves two indigenously developed COVID vaccines, one anti-viral
Updated : 4 years, 2 months ago IST
New Delhi [India], December 28 (ANI): Union Minister of Health and Family Welfare Mansukh Mandaviya on Tuesday announced the approval of two new indigenously developed vaccines and one anti-viral drug for the treatment of the adult patients of COVID-19 having a "high risk of progression o
Read More